Connect with us

National

Coronavirus LIVE Updates: Total 3.22 Crore Covid Cases In India, Active Caseload Lowest Since March – dot newz

Published

on


Coronavirus LIVE Updates: 3,14,48,754 have recovered from the disease. (File)

New Delhi:

India saw a single-day rise of 25,166 new COVID-19 cases on Tuesday, the lowest in 154 days, taking the tally to 3,22,50,679, while the national recovery rate was recorded at 97.51 per cent, the highest since March, according to the latest Health Ministry data on Tuesday. With 88.13 lakh doses given in the last 24 hours, India saw a new single-day vaccination record. 

The number of deaths climbed to 4,32,079 with 437 deaths in the last 24 hours, according to the data updated at 8 am.

The active cases have declined to 3,69,846, the lowest in 146 days. It comprises 1.15 per cent of the total infections, the lowest since March 2020, the Health Ministry said.

Also, 15,63,985 tests were conducted on Monday, taking the cumulative tests conducted so far for detection of COVID-19 in the country to 49,66,29,524. The daily positivity rate was recorded at 1.61 per cent. It has been less than three per cent for the last 22 days.

The weekly positivity rate was recorded at 1.98 per cent. It has been below three per cent for the last 53 days, according to the Health Ministry.

The number of people who have recuperated from the disease surged to 3,14,48,754, while the case fatality rate stands at 1.34 per cent, the data stated.

Cumulatively, 55.47 crore COVID-19 vaccine doses have been administered under the nationwide vaccination drive so far with more than 88.13 lakh doses being administered in the last 24 hours, which is the highest ever vaccination achieved in a single day, the ministry said.

Here are the LIVE Updates on Coronavirus Cases:

Ahead Of Paralympics, Japan Expands COVID-19 Emergency To Battle Surge
Japan’s government on Tuesday expanded a coronavirus state of emergency to seven more regions as it battles a record wave of infections a week before the Paralympic Games. Virus emergency measures that ban restaurants and bars from selling alcohol and require them to close by 8 pm are already in place in Tokyo and five other regions, and had been due to end by August 31. But Prime Minister Yoshihide Suga said the measure would be expanded to additional areas, with the restrictions in all parts of the country running until September 12.
Centre Curbs Export Of Covid Rapid Antigen Test Kits Over Third Wave Concerns

The government on Monday imposed restrictions on the export of Covid rapid antigen testing kits amid several experts warning of a possible third wave of the coronavirus pandemic.

“The export of COVID-19 rapid antigen testing kits… has been put under the restricted category, with immediate effect,” the directorate general of foreign trade (DGFT) said in a notification.

Exporters have to seek a licence or permission from the DGFT for shipping items under the restricted category. Such restrictions are aimed at increasing the domestic availability of the kits.

Cases Are Down In Tamil Nadu, But There’s New COVID-19 Worry

In a new worry for Tamil Nadu, health authorities say the state is facing a kind of vaccination apathy among its residents following a drastic dip in daily coronavirus case numbers from about 36,000 a day during the peak of the second wave in May to less than 2,000 now.

Though on Monday the state administered over 4 lakh doses, its daily average over the last week is 2.23 lakh doses and even more worryingly, only 37 per cent of the population have got one Covid dose and little over 8.2 per cent have got both doses, much less than the national average.

The state has a capacity to inoculate 8 lakh people daily but it managed to cross 5 lakh just one day.



Source link

National

Coronavirus Live News Update: India Creates World Record In Vaccinations With 2.5 Crore Doses In A Day – dot newz

Published

on

By


The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390

India crossed 2.5 crore Covid vaccinations in a day for the first time on Friday as the government raced to deliver a record on Prime Minister Narendra Modi’s birthday. Union Health Minister Mansukh Mandaviya tweeted to confirm the “historic” figure.

The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390.

With 34,403 more people testing positive for COVID-19, India’s overall infection tally has increased to 3,33,81,728, while the count of active cases has dipped to 3,39,056, according to Union health ministry data updated on Friday.

The death count due to the disease has climbed to 4,44,248 with 320 more fatalities being recorded, it said.

The number of active cases now comprises 1.03 per cent of the total infections, while the national COVID-19 recovery rate has been recorded at 97.64 per cent, according to the data updated by the ministry.

It said that active COVID-19 cases in the country decreased by 3,867 cases in a span of 24 hours.

Here are the updates on coronavirus (COVID-19) cases:

Over 7 lakh people vaccinated in Assam on PM’s birthday

A total of 7,09,524 people received the COVID-19 vaccine in Assam on Friday as the state government undertook a mega inoculation drive on the occasion of Prime Minister Narendra Modi’s birthday, a bulletin said.

Over 2.16 crore people have been immunised, and 44.02 lakh of them got both doses of the vaccines, it said.

The special drive was conducted in 4,575 COVID Vaccination Centres (CVCs), of which 4,557 were government sites and 18 private ones.



Source link

Continue Reading

National

WHO Emergency Approval For Covaxin Delayed Till October 5 – dot newz

Published

on

By


The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

New Delhi:

World Health Organisation’s (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.

As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin.

Hanna Nohynek, SAGE member will be introducing session objective setting, an update on regulatory decisions and an overview of Working Group deliverables.

The session will recommend EUA based on the clinical data on Covaxin from phase 1, 2, 3 trial and post-marketing studies on safety, immunogenicity, efficacy and effectiveness.

It will update on global, regional and country-level plans for vaccine safety monitoring.

The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

Meanwhile, Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.

In a series of tweets, Bharat Biotech said that Covaxin clinical trial was fully compiled and available in June 2021.

“#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data was submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,” Bharat Biotech tweeted.

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on the approval process and its timelines, it further said.

“We are continuing to work diligently on obtaining WHO EUL at the earliest,” it added.

Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells.

The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

National

PM Praises Frontline, Health Workers As India Administers Over 2 Crore Doses – dot newz

Published

on

By


PM Praises Frontline, Health Workers As India Administers Record Doses

New Delhi:

As India set a new record on Friday by administering over 2 crores COVID-19 vaccine doses, Prime Minister Narendra Modi dedicated the success of the vaccination drive to the country’s doctors, innovators, administrators, nurses, healthcare and all front-line workers.

“Every Indian would be proud of today’s record vaccination numbers. I acknowledge our doctors, innovators, administrators, nurses, healthcare and all front-line workers who have toiled to make the vaccination drive a success. Let us keep boosting vaccination to defeat COVID-19,” PM Modi tweeted.

Bharatiya Janata Party (BJP) and several state governments have aimed to make Prime Minister Narendra Modi’s birthday historic by setting a record number of Covid vaccinations Friday.

Taking to Twitter, Union Health Minister Mansukh Mandaviya said that the historic feat is a gift to PM Modi on behalf of the health workers and the countrymen.

“#VaccineSeva A gift to Prime minister Narendra Modi on behalf of the health workers and the countrymen. Today, on his birthday, India has crossed the historical figure of administering 2 crore vaccines in a day, setting a new record. Well done India!” Mandaviya tweeted.

India has administered more than one crore COVID-19 vaccines in a day on earlier occasions.The vaccination drive in the country commenced on January 16 with the inoculation of healthcare and frontline workers. At present, India is administering COVID-19 vaccines– Covishield of Serum Institute of India (SII), Bharat Biotech”s Covaxin and Sputnik V.

To ramp up the drive, on April 1, the government had opened Covid-19 vaccination for everyone above the age of 45 years. A month later from May 1, as a part of the third phase of the vaccination drive, India began administering the vaccine in the 18 to 44 years age group.

Since then, the country’s vaccination drive is scaling new heights. On August 9, India’s COVID-19 vaccination coverage crossed the landmark of 50 crores.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

Trending

Copyright © 2017 Dot Newz | Developed by MCVP Group 8